Comparison of monthly vs treat-and-extend regimens for individuals with macular edema who respond well to anti-vascular endothelial growth factor medications: Secondary outcomes from the SCORE2 randomized clinical trial

SCORE2 Investigator Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)337-345
Number of pages9
JournalJAMA Ophthalmology
Volume136
Issue number4
DOIs
StatePublished - Apr 2018

ASJC Scopus Subject Areas

  • Ophthalmology

Cite this